GlassScriptPhysician profile
John J Flanagan
NPI 1902898208
$2,124.43
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2021: $444 · 2022: $328 · 2023: $459 · 2024: $423 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Entertainment: $15.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.57 |
| Entertainment | $15.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $674.59 | 2019-2024 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $409.96 | 2021-2024 | Xarelto |
| Silk Road Medical, INC. | $342.71 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Angiodynamics, INC. | $185.74 | 2024 | Auryon Laser System 100-120 Vac |
| Cook Medical LLC | $161.96 | 2021-2023 | Zilver Ptx |
| Abbott Laboratories | $146.47 | 2025 | Esprit |
| W. L. Gore & Associates, INC. | $43.06 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Smith+Nephew, INC. | $26.08 | 2022 | |
| Solventum Corporation | $24.98 | 2025 | Prevena, V.A.C.Ulta |
| Boston Scientific Corporation | $23.28 | 2025 | Enroute Transcarotid Neuroprotection System |
| Kerecis Limited | $20.79 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Penumbra, INC. | $20.06 | 2023 | Indigo System |
| Musculoskeletal Transplant Foundation INC. | $15.76 | 2023 | |
| Novo Nordisk INC | $14.52 | 2019 | |
| Integra Lifesciences Corporation | $14.47 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Flanagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.